Physician profile
Steven Richards
NPI 1538168489
$1,395.54
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $402 · 2021: $501 · 2022: $67.07 · 2023: $16.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $304.91 | 2019-2022 | |
| Astellas Pharma US INC | $167.89 | 2019-2022 | |
| Antares Pharma, INC. | $157.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.94 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $103.74 | 2019-2021 | |
| Procept Biorobotics Corporation | $89.74 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $81.73 | 2019-2021 | |
| Myovant Sciences INC. | $52.89 | 2021-2022 | |
| 180 Medical, INC. | $44.50 | 2020-2021 | |
| Boston Scientific Corporation | $43.04 | 2019 | |
| Janssen Biotech, INC. | $40.35 | 2019-2021 | |
| Abbvie INC. | $30.00 | 2019-2021 | |
| Urovant Sciences INC | $25.57 | 2021-2022 | |
| Ambu INC. | $25.29 | 2020 | |
| Neotract INC. | $22.78 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $16.19 | 2023 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $14.81 | 2021 | |
| Aytu Biopharma, INC. | $14.57 | 2020 | |
| Clarus Therapeutics INC. | $12.33 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.20 | 2021 | |
| Myriad Genetic Laboratories, INC. | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.